463 related articles for article (PubMed ID: 15447669)
1. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
[TBL] [Abstract][Full Text] [Related]
2. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
3. No role of the dopamine transporter in acute ethanol effects on striatal dopamine dynamics.
Mathews TA; John CE; Lapa GB; Budygin EA; Jones SR
Synapse; 2006 Sep; 60(4):288-94. PubMed ID: 16786536
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
Morice E; Denis C; Giros B; Nosten-Bertrand M
Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
[TBL] [Abstract][Full Text] [Related]
5. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
Zahniser NR; Larson GA; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
[TBL] [Abstract][Full Text] [Related]
6. Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats.
Sabeti J; Gerhardt GA; Zahniser NR
J Pharmacol Exp Ther; 2002 Sep; 302(3):1201-11. PubMed ID: 12183681
[TBL] [Abstract][Full Text] [Related]
7. Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.
Hanania T; Zahniser NR
Alcohol Clin Exp Res; 2002 Apr; 26(4):431-40. PubMed ID: 11981117
[TBL] [Abstract][Full Text] [Related]
8. Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.
Drolet RE; Behrouz B; Lookingland KJ; Goudreau JL
Neurotoxicology; 2004 Sep; 25(5):761-9. PubMed ID: 15288507
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine.
Chefer VI; Kieffer BL; Shippenberg TS
Neuroscience; 2004; 127(2):497-503. PubMed ID: 15262338
[TBL] [Abstract][Full Text] [Related]
11. Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice.
Rothman RB; Carroll FI; Morales M; Rowley DL; Rice KC; Dersch CM; Donovan DM
Synapse; 2002 May; 44(2):94-105. PubMed ID: 11891881
[TBL] [Abstract][Full Text] [Related]
12. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
14. L-arginine increases dopamine transporter activity in rat striatum via a nitric oxide synthase-dependent mechanism.
Volz TJ; Schenk JO
Synapse; 2004 Dec; 54(3):173-82. PubMed ID: 15452864
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
18. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression.
Mathews TA; Fedele DE; Coppelli FM; Avila AM; Murphy DL; Andrews AM
J Neurosci Methods; 2004 Dec; 140(1-2):169-81. PubMed ID: 15589347
[TBL] [Abstract][Full Text] [Related]
19. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
[TBL] [Abstract][Full Text] [Related]
20. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
